We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-3.05%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$52.7B
AUM Growth
-$2.48B
(-4.5%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
2,367
New
187
Increased
1,008
Reduced
966
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$237M |
| 2 |
Pfizer
PFE
|
+$200M |
| 3 |
Moderna
MRNA
|
+$143M |
| 4 |
EPAM Systems
EPAM
|
+$106M |
| 5 |
Gilead Sciences
GILD
|
+$94.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$138M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
AngloGold Ashanti
AU
|
+$112M |
| 4 |
Costco
COST
|
+$111M |
| 5 |
Microsoft
MSFT
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 15.7% |
| 3 | Industrials | 11.74% |
| 4 | Financials | 11.69% |
| 5 | Consumer Discretionary | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LX
1826
LexinFintech Holdings
LX
$241M
| $492K | ﹤0.01% |
187,759
| – | – |
|
1827
XPEL
XPEL
$1.32B
| $491K | ﹤0.01% |
9,336
-11,512
| -55% | -$711K |
|
1828
Sally Beauty Holdings
SBH
$1.54B
| $489K | ﹤0.01% |
31,485
-9,828
| -24% | -$170K |
|
1829
Helios Technologies
HLIO
$2.71B
| $488K | ﹤0.01% |
6,085
+1,279
| +27% | +$102K |
|
1830
Trupanion
TRUP
$1.37B
| $486K | ﹤0.01% |
5,454
+3,141
| +136% | +$289K |
|
1831
Amphastar Pharmaceuticals
AMPH
$838M
| $485K | ﹤0.01% |
13,499
+2,924
| +28% | +$82.9K |
|
1832
Sunstone Hotel Investors
SHO
$2B
| $483K | ﹤0.01% |
40,987
+13,540
| +49% | +$154K |
|
1833
WD-40
WDFC
$3.12B
| $483K | ﹤0.01% |
2,634
-309
| -10% | -$66K |
|
|
PENG
1834
Penguin Solutions Inc
PENG
$3.1B
| $483K | ﹤0.01% |
18,698
-4,070
| -18% | -$115K |
|
1835
CONMED
CNMD
$1.47B
| $481K | ﹤0.01% |
3,236
+24
| +0.7% | +$3.35K |
|
1836
Marathon Digital Holdings
MARA
$3.86B
| $478K | ﹤0.01% |
17,109
-27,988
| -62% | -$727K |
|
|
VRE
1837
DELISTED
Veris Residential
VRE
| $478K | ﹤0.01% |
27,496
+14,668
| +114% | +$254K |
|
1838
1-800-Flowers.com
FLWS
$254M
| $477K | ﹤0.01% |
37,421
+15,918
| +74% | +$274K |
|
1839
Phibro Animal Health
PAHC
$1.38B
| $472K | ﹤0.01% |
23,647
+2,738
| +13% | +$55.3K |
|
1840
BioMarin Pharmaceuticals
BMRN
$13.6B
| $471K | ﹤0.01% |
6,110
+3,809
| +166% | +$319K |
|
1841
Hamilton Lane
HLNE
$5.68B
| $469K | ﹤0.01% |
6,069
+3,217
| +113% | +$268K |
|
1842
Pebblebrook Hotel Trust
PEB
$2.02B
| $467K | ﹤0.01% |
19,082
+3,146
| +20% | +$72.2K |
|
1843
POSCO
PKX
$17.3B
| $466K | ﹤0.01% |
7,859
+1,091
| +16% | +$64.4K |
|
|
GLDD
1844
DELISTED
Great Lakes Dredge & Dock
GLDD
| $465K | ﹤0.01% |
33,125
-533
| -2% | -$7.67K |
|
|
SNBR
1845
DELISTED
Sleep Number
SNBR
| $465K | ﹤0.01% |
9,171
+224
| +3% | +$15.2K |
|
1846
Ducommun
DCO
$3.08B
| $464K | ﹤0.01% |
+8,853
| New | +$422K |
|
1847
Magnachip Semiconductor
MX
$144M
| $464K | ﹤0.01% |
+27,414
| New | +$492K |
|
1848
Ultrapar
UGP
$6.3B
| $461K | ﹤0.01% |
152,134
-5,818
| -4% | -$15.8K |
|
|
ISEE
1849
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $461K | ﹤0.01% |
27,420
-57,189
| -68% | -$845K |
|
1850
Edgewell Personal Care
EPC
$1.3B
| $459K | ﹤0.01% |
12,654
+527
| +4% | +$21.5K |
|
Similar funds
VGA
AQR Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, AQR Capital Management held 2,367 positions worth $52.7B, down 4.5% from $55.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
AQR Capital Management's Q1 2022 filing shows 187 new, 1,008 increased, 966 reduced and 158 closed positions. Its largest new stake was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M. The largest sale was Target, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
- AQR Capital Management's largest Q1 2022 buy was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M.
- AQR Capital Management added most to Meta Platforms (Facebook) in Q1 2022, an estimated $237M increase.
- AQR Capital Management's biggest Q1 2022 reduction was Target, cutting an estimated $138M.
- AQR Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $25.4M.
- AQR Capital Management's ten largest holdings make up 16% of its $52.7B portfolio in Q1 2022.
- AQR Capital Management opened 187 new positions and closed 158 in Q1 2022.
- AQR Capital Management's portfolio value fell 4.5% quarter-over-quarter to $52.7B.
Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.